Regulation of skin inflammation and angiogenesis by EC-SOD via HIF-1α and NF-κB pathways

Younghwa Kim, Byung Hak Kim, Hyangkyu Lee, Byeongwook Jeon, Yun Sang Lee, Myung Ja Kwon, Tae Yoon Kim

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Extracellular superoxide dismutase (EC-SOD) is an antioxidant enzyme that breaks down superoxide anion into oxygen and hydrogen peroxide in extracellular spaces and plays key roles in controlling pulmonary and vascular diseases in response to oxidative stresses. We aimed to investigate the role of EC-SOD in angiogenesis and inflammation in chronic inflammatory skin disorders such as psoriasis. Overexpressed EC-SOD reduced expression of angiogenic factors and proinflammatory mediators in hypoxia-induced keratinocytes and in ultraviolet B-irradiated mice, whereas the expression of the antiangiogenic factor tissue inhibitor of metalloproteinase-1 and anti-inflammatory cytokine interleukin-10 were increased. EC-SOD decreased new vessel formation, epidermal edema, and inflammatory cell infiltration in UVB-irradiated transgenic mice. Moreover, cells treated with recombinant human EC-SOD showed inhibited endothelial tube formation and cell proliferation. Overall, the antiangiogenic and anti-inflammatory effects of EC-SOD might be due to suppression of hypoxia-inducible factor-1α, protein kinase C, and nuclear factor-κB expression. Furthermore, EC-SOD expression in tissue from psoriasis patients was markedly decreased in psoriatic lesional and nonlesional skins from psoriasis patients in comparison to normal skin from healthy volunteers. Together, these results suggest that EC-SOD may provide a novel therapeutic approach to treating angiogenic and inflammatory skin diseases such as psoriasis.

Original languageEnglish
Pages (from-to)1985-1995
Number of pages11
JournalFree Radical Biology and Medicine
Volume51
Issue number11
DOIs
Publication statusPublished - 2011 Dec 1

Fingerprint

Superoxide Dismutase
Skin
Inflammation
Psoriasis
Anti-Inflammatory Agents
Hypoxia-Inducible Factor 1
Tissue Inhibitor of Metalloproteinase-1
Oxidative stress
Angiogenesis Inducing Agents
Cell proliferation
Extracellular Space
Vascular Diseases
Keratinocytes
Infiltration
Skin Diseases
Superoxides
Interleukin-10
Protein Kinase C
Hydrogen Peroxide
Transgenic Mice

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Physiology (medical)

Cite this

Kim, Younghwa ; Kim, Byung Hak ; Lee, Hyangkyu ; Jeon, Byeongwook ; Lee, Yun Sang ; Kwon, Myung Ja ; Kim, Tae Yoon. / Regulation of skin inflammation and angiogenesis by EC-SOD via HIF-1α and NF-κB pathways. In: Free Radical Biology and Medicine. 2011 ; Vol. 51, No. 11. pp. 1985-1995.
@article{7e13eedee0534245880401df311710eb,
title = "Regulation of skin inflammation and angiogenesis by EC-SOD via HIF-1α and NF-κB pathways",
abstract = "Extracellular superoxide dismutase (EC-SOD) is an antioxidant enzyme that breaks down superoxide anion into oxygen and hydrogen peroxide in extracellular spaces and plays key roles in controlling pulmonary and vascular diseases in response to oxidative stresses. We aimed to investigate the role of EC-SOD in angiogenesis and inflammation in chronic inflammatory skin disorders such as psoriasis. Overexpressed EC-SOD reduced expression of angiogenic factors and proinflammatory mediators in hypoxia-induced keratinocytes and in ultraviolet B-irradiated mice, whereas the expression of the antiangiogenic factor tissue inhibitor of metalloproteinase-1 and anti-inflammatory cytokine interleukin-10 were increased. EC-SOD decreased new vessel formation, epidermal edema, and inflammatory cell infiltration in UVB-irradiated transgenic mice. Moreover, cells treated with recombinant human EC-SOD showed inhibited endothelial tube formation and cell proliferation. Overall, the antiangiogenic and anti-inflammatory effects of EC-SOD might be due to suppression of hypoxia-inducible factor-1α, protein kinase C, and nuclear factor-κB expression. Furthermore, EC-SOD expression in tissue from psoriasis patients was markedly decreased in psoriatic lesional and nonlesional skins from psoriasis patients in comparison to normal skin from healthy volunteers. Together, these results suggest that EC-SOD may provide a novel therapeutic approach to treating angiogenic and inflammatory skin diseases such as psoriasis.",
author = "Younghwa Kim and Kim, {Byung Hak} and Hyangkyu Lee and Byeongwook Jeon and Lee, {Yun Sang} and Kwon, {Myung Ja} and Kim, {Tae Yoon}",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/j.freeradbiomed.2011.08.027",
language = "English",
volume = "51",
pages = "1985--1995",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "11",

}

Regulation of skin inflammation and angiogenesis by EC-SOD via HIF-1α and NF-κB pathways. / Kim, Younghwa; Kim, Byung Hak; Lee, Hyangkyu; Jeon, Byeongwook; Lee, Yun Sang; Kwon, Myung Ja; Kim, Tae Yoon.

In: Free Radical Biology and Medicine, Vol. 51, No. 11, 01.12.2011, p. 1985-1995.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Regulation of skin inflammation and angiogenesis by EC-SOD via HIF-1α and NF-κB pathways

AU - Kim, Younghwa

AU - Kim, Byung Hak

AU - Lee, Hyangkyu

AU - Jeon, Byeongwook

AU - Lee, Yun Sang

AU - Kwon, Myung Ja

AU - Kim, Tae Yoon

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Extracellular superoxide dismutase (EC-SOD) is an antioxidant enzyme that breaks down superoxide anion into oxygen and hydrogen peroxide in extracellular spaces and plays key roles in controlling pulmonary and vascular diseases in response to oxidative stresses. We aimed to investigate the role of EC-SOD in angiogenesis and inflammation in chronic inflammatory skin disorders such as psoriasis. Overexpressed EC-SOD reduced expression of angiogenic factors and proinflammatory mediators in hypoxia-induced keratinocytes and in ultraviolet B-irradiated mice, whereas the expression of the antiangiogenic factor tissue inhibitor of metalloproteinase-1 and anti-inflammatory cytokine interleukin-10 were increased. EC-SOD decreased new vessel formation, epidermal edema, and inflammatory cell infiltration in UVB-irradiated transgenic mice. Moreover, cells treated with recombinant human EC-SOD showed inhibited endothelial tube formation and cell proliferation. Overall, the antiangiogenic and anti-inflammatory effects of EC-SOD might be due to suppression of hypoxia-inducible factor-1α, protein kinase C, and nuclear factor-κB expression. Furthermore, EC-SOD expression in tissue from psoriasis patients was markedly decreased in psoriatic lesional and nonlesional skins from psoriasis patients in comparison to normal skin from healthy volunteers. Together, these results suggest that EC-SOD may provide a novel therapeutic approach to treating angiogenic and inflammatory skin diseases such as psoriasis.

AB - Extracellular superoxide dismutase (EC-SOD) is an antioxidant enzyme that breaks down superoxide anion into oxygen and hydrogen peroxide in extracellular spaces and plays key roles in controlling pulmonary and vascular diseases in response to oxidative stresses. We aimed to investigate the role of EC-SOD in angiogenesis and inflammation in chronic inflammatory skin disorders such as psoriasis. Overexpressed EC-SOD reduced expression of angiogenic factors and proinflammatory mediators in hypoxia-induced keratinocytes and in ultraviolet B-irradiated mice, whereas the expression of the antiangiogenic factor tissue inhibitor of metalloproteinase-1 and anti-inflammatory cytokine interleukin-10 were increased. EC-SOD decreased new vessel formation, epidermal edema, and inflammatory cell infiltration in UVB-irradiated transgenic mice. Moreover, cells treated with recombinant human EC-SOD showed inhibited endothelial tube formation and cell proliferation. Overall, the antiangiogenic and anti-inflammatory effects of EC-SOD might be due to suppression of hypoxia-inducible factor-1α, protein kinase C, and nuclear factor-κB expression. Furthermore, EC-SOD expression in tissue from psoriasis patients was markedly decreased in psoriatic lesional and nonlesional skins from psoriasis patients in comparison to normal skin from healthy volunteers. Together, these results suggest that EC-SOD may provide a novel therapeutic approach to treating angiogenic and inflammatory skin diseases such as psoriasis.

UR - http://www.scopus.com/inward/record.url?scp=80255133209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80255133209&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2011.08.027

DO - 10.1016/j.freeradbiomed.2011.08.027

M3 - Article

C2 - 21925591

AN - SCOPUS:80255133209

VL - 51

SP - 1985

EP - 1995

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 11

ER -